Both vaccinated + DSS and vaccinated + therapeutic + DSS mice had similar and high levels of anti-CTB-KDEL IgA antibodies in the intestine on both days, indicating that ADAs were present when CTB-KDEL was administered for the treatment of colitis (Figure 5D). This evidence concerns the gene CD79A and colitis.